Gould Capital »

Crispr Therapeutics shares owned by Gould Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Gould Capital from 13F filings

Historical chart of Gould Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Gould Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Gould Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.9k 105 46.98
2024-06-30 $5.7k 105 54.01
2024-03-31 $7.2k 105 68.16
2023-12-31 $6.6k 105 62.60
2023-09-30 $4.7k 110 42.41
2023-06-30 $6.2k 110 56.14
2023-03-31 $5.0k 110 45.23
2022-12-31 $3.7k 90 40.66
2022-09-30 $6.0k 90 66.67
2022-06-30 $5.0k 90 55.56
2022-03-31 $6.0k 90 66.67
2021-12-31 $7.0k 90 77.78